Results for tag: "Adempas"

Adempas (riociguat) is a medication used to treat pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It is a type of cardiovascular drug, which works by relaxing the blood vessels in the lungs to improve blood flow and reduce the workload on the heart. Adempas is a vasodilator, meaning it widens the blood vessels, allowing more blood to flow through them. It is also used to treat people with PAH who have not responded to other treatments. Adempas is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2013. It is manufactured by Bayer AG and marketed by Merck & Co. in the United States. Other companies involved in the Adempas market include Actelion Pharmaceuticals, Gilead Sciences, and United Therapeutics. Show Less Read more